GlassScriptPhysician profile
Stephen Kuehn
NPI 1750317533
$56,876.12
in general payments reported to CMS, 2019-2025
48 companies · $22K in 2025
The $22K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,266 · 2020: $5,291 · 2021: $4,539 · 2022: $13K · 2023: $1,734 · 2024: $2,027 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $7,003 · Consulting Fee: $4,802 · Travel and Lodging: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,126.05 |
| Food and Beverage | $7,002.77 |
| Consulting Fee | $4,802.19 |
| Travel and Lodging | $1,397.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $18,242.67 | 2023-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $10,306.10 | 2019-2024 | Xarelto |
| Philips North America LLC | $3,634.79 | 2019-2025 | Elca, Azurion 7 M20 |
| Boston Scientific Corporation | $3,335.98 | 2019-2025 | Avvigo Guidance System, Synergy, Lux-Dx Insertable Cardiac Monitor |
| Medtronic Vascular, INC. | $2,668.41 | 2019-2020 | |
| Biotronik INC. | $2,581.00 | 2019-2022 | |
| Penumbra, INC. | $2,383.37 | 2019-2025 | Indigo System, Penumbra System |
| Edwards Lifesciences Corporation | $1,897.18 | 2019-2022 | |
| Abbott Laboratories | $1,267.13 | 2019-2025 | Diamondback Peripheral, Diamondback Coronary, Cardiomems |
| Amgen INC. | $1,239.10 | 2019-2025 | Repatha, Repatha |
| Abiomed | $1,202.03 | 2019-2024 | Impella |
| Pfizer INC. | $1,157.64 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $753.05 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $711.44 | 2019-2022 | |
| Cardiovascular Systems INC. | $505.00 | 2019-2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $478.84 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $459.24 | 2019-2024 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $456.13 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $445.97 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $359.18 | 2019-2025 | |
| Medtronic, INC. | $347.84 | 2021-2025 | Symplicity G3, Hawkone, Ffrangio |
| Cordis US Corp. | $303.81 | 2025 | Mynx Control Venous |
| Bard Peripheral Vascular, INC. | $281.29 | 2020-2021 | |
| Shockwave Medical, INC | $218.60 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $161.32 | 2019-2021 | |
| Cvrx, INC. | $152.14 | 2023 | Barostim Neo System |
| Portola Pharmaceuticals, LLC | $140.21 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $136.79 | 2019-2020 | |
| Zoll Circulation INC | $130.33 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $126.79 | 2023-2025 | Uptravi, Opsynvi, Opsumit |
| Itamar Medical INC | $120.24 | 2023 | Watchpatone |
| Amarin Pharma, INC. | $106.35 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.48 | 2022-2024 | |
| Baxter Healthcare | $82.57 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Teleflex LLC | $55.19 | 2019 | |
| Impulse Dynamics (USA) INC. | $54.11 | 2022 | |
| Esperion Therapeutics, INC. | $43.48 | 2020-2023 | Nexletol |
| W. L. Gore & Associates, INC. | $36.86 | 2024 | C3 Delivery System |
| Angiodynamics, INC. | $30.79 | 2024 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $29.32 | 2022-2024 | Verquvo |
| Cardinal Health 200 LLC | $24.40 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $23.00 | 2024 | Arcalyst |
| Heartflow, INC. | $19.33 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.02 | 2019 | |
| Terumo Medical Corporation | $18.24 | 2022 | |
| Elutia, INC. | $15.67 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.17 | 2019 | |
| Gilead Sciences, INC. | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kuehn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.